Return
DARA-VTD AND ASCT plus LENALIDOMIDE LED TO HIGH COMPLETE REIMISSION AND MINIMAL RESIDUAL DISEASE NEGATIVITY RATES BY NGF: A REAL-WORLD STUDY OF THE TUSCAN MYELOMA NETWORK IN 228 PATIENTS
V
C
B
B
R
C
P
D
C
M
F
A
P
B
B
G
P
N
T
G
B
G
DOI:.png)
Abstract
En
Journal
IF:
7.9
Papers:
6.4K
Citations:
2.2W
